In breast cancer, H19 acts to sponge miRNA let-7 and inhibit its biological function, subsequently leading to the elevation of LIN28, the core pluripotency factor that is crucial for the maintenance of breast cancer stem cells (BCSCs) 62. The gene discussed is H19; the disease is breast carcinoma.